- PacRoots Cannabis employs genetic modification to customize cannabis strains in bid to enhance product potency, quality
- Company has strategic licensing agreement with Phenome One, a bio-tech firm boasting a database of over 350 unique live cannabis strains
- Partnership allows PacRoots ability to optimize genetic makeup of its cannabis crop based upon plant’s intended end use
- Use of genetic modification can also help companies cultivate plants which are better suited towards overall yield enhancement, thereby boosting overall profit margins
In the late 1860s, Friar Gregor Mendel, an Augustinian monk and scientist living in a monastery in the depths of the Austrian empire, set about cross-breeding different species of garden pea plants – an experiment which would ultimately plant the seed for genetic modifications in modern agriculture. Over 150 years later, the cannabis industry is picking up from where Friar Mendel left off. PacRoots Cannabis (CSE: PACR), a Canada-based company, has sought to adopt a genetics-focused approach towards producing premium quality cannabis products—positioning itself to become a trailblazer in providing industry-leading strains not currently available in the regulated market.
PacRoots expects to be cash flow positive within its first year of trading following the sales from the 100-acre Hemp Project, in Rock Creek, BC. The company has embraced Phenome One’s growing IP, methods and systems; including systematic planting of young hardy plants in rows vs a seed spread, advanced weed suppression and…
NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.